RenovoRx
AcquiredRenovoRx is developing innovative solutions for targeted delivery of fluids to selected sites in the peripheral vascular system.
What it does
RenovoRx is a pioneering health company focused on developing innovative solutions for targeted delivery of fluids to specific sites in the peripheral vascular system. With a core focus on delivering diagnostic and therapeutic agents at high concentrations to specific vasculature without perfusion overlap to other regions, RenovoRx's technology offers a paradigm shift in targeted fluid delivery. Having received FDA clearance for the RenovoCath™, RenovoRx is now poised to introduce its groundbreaking technology to the clinical market. RenovoRx's commitment to advancing targeted delivery methods in the peripheral vascular system showcases its dedication to improving patient outcomes and revolutionizing the field of healthcare.
Its site says now · captured 2026-08-23
RenovoRx – Developing Innovative Solutions for Targeted Delivery
RenovoRx has developed RenovoCath™, a dual-balloon infusion catheter, for targeted chemotherapy delivery for pancreatic cancer patients.
Next to it in Healthcare and bio · targeted vascular drug delivery
- JWP GmbH Drug Eluting SolutionsPlug and Play
JWP Drug Elution Solutions develops "in-bone micro-pharmacies" to transform orthopedic surgery by simultaneously controlling infection and actively regenerating bone, turning two-stage operations into one-stage.
- Avro Life ScienceY Combinator W18
Skin patches for generic drug delivery.
- Intact TherapeuticsY Combinator W19
Smart gels for local drug delivery to the gut
- MeraclePlug and Play
Meracle increase the efficacy of medication delivered into the lungs of chronic respiratory patients, while tracking intake data to augment the assessment of treatment outcomes
- Sixfold BioscienceY Combinator W18
Delivering RNA therapies.
- Indee LabsSOSV SOSV IndieBio 02
Developing scalable hardware for gene delivery
- XFOREST TherapeuticsPlug and Play
xFOREST Therapeutics is a biotech company focused on RNA-targeted small-molecule drug discovery using RNA-library-based HTS.
- CyGenica Ltd.SOSV SOSV IndieBio RebelBio 04
Delivering therapeutic molecules directly into living cells